What is ABLE Labs?
Founded in 2021, ABLE Labs specializes in the design and deployment of laboratory automation solutions. The company's core value proposition lies in its user-friendly liquid handling robots that allow researchers to automate repetitive tasks without requiring specialized programming expertise. By focusing on precision and 24-hour technical support, ABLE Labs addresses the critical pain points of manual error and throughput limitations in diagnostic and university laboratories. Their market position is defined by a commitment to enhancing research efficiency, enabling scientists to dedicate more time to high-value analytical work rather than routine liquid transfers.
How much funding has ABLE Labs raised?
ABLE Labs has raised a total of $8.7M across 1 funding round:
Series A
$8.7M
Series A (2026): $8.7M with participation from Capstone Partners, Innopolis Partners, Industrial Bank of Korea, and Magna Investment
Key Investors in ABLE Labs
Capstone Partners
A middle-market investment banking firm providing comprehensive financial advisory and equity capital financing services.
Innopolis Partners
A venture capital firm specializing in the commercialization of public technology and deep tech investments, with a focus on early-stage scale-up growth.
Industrial Bank of Korea
A leading financial institution providing specialized banking services, loans, and asset management solutions to small and midsized enterprises.
What's next for ABLE Labs?
With this major enterprise-level funding, ABLE Labs is poised to enter a phase of rapid commercial expansion. The strategic roadmap likely involves scaling production capabilities to meet the increasing demand from global pharmaceutical R&D centers and diagnostic facilities. Furthermore, the capital will likely be deployed toward enhancing the software ecosystem surrounding their hardware, ensuring that their automated pipetting solutions remain at the forefront of the deep tech landscape. As the company matures, the focus will shift toward international market penetration and the potential integration of AI-driven analytics into their existing robotic platforms, further cementing their role as a leader in the laboratory automation sector.
See full ABLE Labs company page
